DEROSA, LISA
 Distribuzione geografica
Continente #
NA - Nord America 416
EU - Europa 165
AS - Asia 45
AF - Africa 4
OC - Oceania 2
SA - Sud America 1
Totale 633
Nazione #
US - Stati Uniti d'America 410
FR - Francia 100
IT - Italia 29
CN - Cina 17
DE - Germania 10
VN - Vietnam 10
GB - Regno Unito 6
UA - Ucraina 6
SG - Singapore 5
CA - Canada 4
IN - India 4
IE - Irlanda 3
ZA - Sudafrica 3
AU - Australia 2
DK - Danimarca 2
JP - Giappone 2
PA - Panama 2
PT - Portogallo 2
SA - Arabia Saudita 2
AM - Armenia 1
CL - Cile 1
FI - Finlandia 1
HU - Ungheria 1
IM - Isola di Man 1
KR - Corea 1
MA - Marocco 1
NL - Olanda 1
NO - Norvegia 1
PL - Polonia 1
RU - Federazione Russa 1
TH - Thailandia 1
TR - Turchia 1
TW - Taiwan 1
Totale 633
Città #
Fairfield 46
Buffalo 37
Houston 37
Woodbridge 35
Seattle 25
Cambridge 22
Ann Arbor 21
Ashburn 18
Santa Cruz 18
Wilmington 13
Serra 10
El Paso 9
Dong Ket 8
Shanghai 6
University Park 6
Clearwater 5
Mountain View 5
Paris 5
Chicago 4
Los Angeles 4
Phoenix 4
Beijing 3
Dublin 3
Gaeta 3
Muizenberg 3
Ottawa 3
San Francisco 3
Spoltore 3
Wuhan 3
Bengaluru 2
Bordeaux 2
Denver 2
Des Moines 2
Easton 2
Hangzhou 2
Hyères 2
La Spezia 2
Lake Forest 2
Madison 2
Riva 2
Riyadh 2
Singapore 2
Sunnyvale 2
Torcy 2
Boardman 1
Bremen 1
Brooklyn 1
Büdelsdorf 1
Capannoli 1
Capannori 1
Coventry 1
Crugers 1
Dalian 1
Dallas 1
Douglas 1
Frankfurt Am Main 1
Gangnam-gu 1
Gdansk 1
Guangzhou 1
Hartford 1
Istanbul 1
Jacksonville 1
Lappeenranta 1
Leeds 1
Miami 1
Milpitas 1
Netherby 1
New York 1
Oslo 1
Providence 1
Provo 1
Pueblo Nuevo 1
Pune 1
Rome 1
Rueil-Malmaison 1
Saint Cloud 1
San Diego 1
San Jose 1
Scranton 1
Strasbourg 1
Suita 1
Szeged 1
Taichung 1
Tampa 1
Toronto 1
Torres Novas 1
Tuttlingen 1
Washington 1
Yellow Springs 1
Yerevan 1
Yokohama 1
Totale 439
Nome #
New Prognostic factors for second-line targeted therapy (TT) in metastatic renal cell carcinoma (mRCC)., file e0d6c927-4fef-fcf8-e053-d805fe0aa794 166
[18F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: Preliminary results, file e0d6c927-530d-fcf8-e053-d805fe0aa794 147
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients, file e0d6c931-1d35-fcf8-e053-d805fe0aa794 136
Feasibility and efficacy of 223Ra-dichloride (223Ra) to treat bone metastases in patients (pts) with castration resistant prostate cancer (mCRPC), file e0d6c927-46b5-fcf8-e053-d805fe0aa794 121
null, file e0d6c927-e576-fcf8-e053-d805fe0aa794 85
Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients, file e0d6c92b-384d-fcf8-e053-d805fe0aa794 7
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients, file e0d6c927-f523-fcf8-e053-d805fe0aa794 5
Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680–7, file e0d6c929-c55e-fcf8-e053-d805fe0aa794 2
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients, file e0d6c929-fb96-fcf8-e053-d805fe0aa794 2
EARLY AND COMPLETE CLINICAL RESPONSE TO SUNITINIB IN A PATIENT WITH METASTATIC RENAL CANCER, file e0d6c92f-8434-fcf8-e053-d805fe0aa794 1
Totale 672
Categoria #
all - tutte 1.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.108


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201988 0 0 0 0 0 0 0 1 16 14 32 25
2019/2020125 19 10 5 12 11 12 9 10 15 7 9 6
2020/202186 5 6 6 5 7 5 12 5 10 10 5 10
2021/2022100 11 1 6 19 17 3 5 3 3 3 23 6
2022/202388 2 9 23 10 7 4 5 7 4 4 8 5
2023/2024135 3 8 9 3 10 32 35 35 0 0 0 0
Totale 672